LighTouch sets US filing date for "fingerstick-free" glucose test
This article was originally published in Clinica
Aiming to improve the monitoring of diabetes, US firm LighTouch Medical has developed a noninvasive glucose test that could eliminate the need for traditional fingerstick testing. The Bryn Athyn, Pennsylvania firm expects to file its desktop-based instrument for US approval in the first half of 2006.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.